C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2004
12/01/2004	EP1481000A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
12/01/2004	EP1480998A1 Intermediates and methods for making heptapeptide oxytocin analogues
12/01/2004	EP1480961A1 Glutaminyl based dpiv inhibitors
12/01/2004	EP1480946A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity
12/01/2004	EP1480668A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization,or both, in humans
12/01/2004	EP1480666A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
12/01/2004	EP1480665A2 Peptides for recognition and targeting of glial cell tumors
12/01/2004	EP1012180B1 Hepatitis c inhibitor peptide analogues
12/01/2004	CN1551887A Novel depsipeptides and process for preparing same
12/01/2004	CN1551760A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
11/2004
11/30/2004	US6825347 Uronium and immonium salts for peptide coupling
11/30/2004	US6825318 Vaccine for obesity therapy; hybrid polypeptides
11/30/2004	US6825003 Cyclic lipopeptide acylase
11/30/2004	US6824994 Peptide ligands that mimic sensor kinases and inhibit response regulators
11/30/2004	US6824981 Reporter signals for use as diagnostic tools in genetic engineering
11/30/2004	US6824783 Delaying the onset of aids in an hiv- 1 infected individual, comprising administering a peptide which inhibits membrane fusion-associated events, i.e. syncytia formation between hiv-1 infected cells and cells uninfected
11/30/2004	CA2173150C Novel peptide derivatives
11/25/2004	WO2004101742A2 Protease inhibitors for coronaviruses and sars-cov and the use thereof
11/25/2004	WO2004101610A1 Oligopeptide
11/25/2004	WO2004101606A2 Novel peptides that bind to the erythropoietin receptor
11/25/2004	WO2004101603A1 Statine derivatives for the treatment of alzheimer's disease
11/25/2004	WO2004093662A3 Method for detecting prognosis of cancer
11/25/2004	WO2004072095A3 Cyclized peptides as exotoxin antagonists
11/25/2004	WO2004034977A3 Orally administered peptides synergize statin activity
11/25/2004	WO2003103718A3 Intracellular delivery of biological effectors
11/25/2004	WO2003082924A8 Immunotherapeutic and immunoprophylactic reagents
11/25/2004	US20040236519 Libraries of confomationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235745 Basic polypeptide against Grampositive and Gramnegative bacteria; noncytoxic
11/25/2004	US20040235744 Purified nitric oxide synthase
11/25/2004	US20040235716 Novel cyclosporins
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040234617 Water extraction; centrifuging; separation; cooling; freeze drying; hypotensive agents
11/25/2004	US20040234524 Anti-osteopontin antibody and use thereof
11/25/2004	US20040234454 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/25/2004	DE10320781A1 Acylierte Nonadepsipeptide Acylated nonadepsipeptides
11/25/2004	CA2525568A1 Novel peptides that bind to the erythropoietin receptor
11/25/2004	CA2525496A1 Statine derivatives for the treatment of alzheimer's disease
11/25/2004	CA2524882A1 Protease inhibitors for coronaviruses and sars-cov and the use thereof
11/25/2004	CA2524456A1 Apo2l (trail) receptor binding peptides and uses thereof
11/24/2004	EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins
11/24/2004	EP1479690A1 Cytokine isolated from an insect
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478659A2 Biologically active peptides
11/24/2004	EP1478405A2 Beta-homolysine conjugates and their use as transport enhancer
11/24/2004	EP1478383A2 Compositions and methods for promoting myocardial and peripheral angiogenesis
11/24/2004	EP1478328A2 Bioactive keratin peptides
11/24/2004	EP1450846A4 Self-assembling polymers, and materials fabricated therefrom
11/24/2004	EP1285000B1 Adnf mixtures for enhancing learning and memory
11/24/2004	EP0998493B1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
11/24/2004	EP0914333B1 Peptide derivatives
11/24/2004	EP0717752B1 Therapeutic compounds
11/24/2004	EP0656012B1 T cell epitopes of ryegrass pollen allergen
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1549824A Peptidic compounds selectively binding to p-selectin
11/24/2004	CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity.
11/23/2004	US6822074 Comprises cyclization of precursor; for improved yield
11/23/2004	US6821954 Compounds and uses thereof in treating bone disorders
11/23/2004	US6821953 Methods for treating and preventing damage to mucosal tissue
11/23/2004	US6821952 Peptide-based compounds having light-emitting moieties to monitor peptide, cytokine, drug, and hormone receptors at the cellular level
11/23/2004	US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure
11/23/2004	US6821517 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/23/2004	CA2171446C Pseudo- and non-peptide bradykinin receptor antagonists
11/23/2004	CA2012482C Hepatitis c diagnostics and vaccines
11/18/2004	WO2004099376A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	WO2004099239A1 Acylated lysobactin-type nonadepsipeptides
11/18/2004	WO2004099237A1 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure
11/18/2004	WO2004099135A2 Hiv prodrugs cleavable by cd26
11/18/2004	WO2004098644A1 Prodrugs cleavable by cd26
11/18/2004	WO2004098629A1 GnRH CONJUGATES COMPRISING A PHOTOSENSITIZER FOR PHOTODYNAMIC THERAPY
11/18/2004	WO2004098628A2 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	WO2004098627A1 Inhibition of platelet aggregation through acyclovir and two peptide antagonists
11/18/2004	WO2004080288A3 Post-translational modifications of proteins as regulatory switches
11/18/2004	WO2004078778A3 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
11/18/2004	WO2004069857A3 “peptides, compositions and uses thereof”
11/18/2004	WO2004035606A3 Bace binding peptides and uses thereof
11/18/2004	WO2004011902A3 Improved systems and methods for analysis of protein post-translational modification
11/18/2004	WO2003090697B1 Chimeric hybrid analgesics
11/18/2004	US20040230380 Novel proteins with altered immunogenicity
11/18/2004	US20040230035 protease/thrombin inhibitors
11/18/2004	US20040229812 Mimetic insect allatostatin analogs for insect control
11/18/2004	US20040229811 Compounds and methods for modulating desmosomal cadherin-mediated functions
11/18/2004	US20040229810 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits
11/18/2004	US20040229801 Provides anti-fungal compounds, including peptides and peptidomimetics having anti-fungal activity alone, and in combination with other agents that have anti-fungal activity, and methods of using the compounds for killing or inhibit growth of yeast, mold, slimes
11/18/2004	US20040229784 Administering peptide hormones derived from atrial natriuretic factors/peptides (ANP), atriopeptin, as anticarcinogenic agents
11/18/2004	US20040229280 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection
11/18/2004	US20040229236 preparing pristinamycin IIA and/or IIB by introducing a disabling mutation into a gene that encodes 3-hydroxypicolinic acid:adenosine 5'-monopiosphate ligase; selecting and culturing cells containing the mutated gene that are blocked in the production of pristinamycin IA and IB
11/18/2004	US20040229223 Using receptor binding peptide to treat and prevent pancreatic disorders; peptide mimetics; antidiabetic agents
11/18/2004	DE10047857B4 Verfahren zur selektiven biokatalytischen Modifizierung von Peptiden und Proteinen Biocatalytic process for the selective modification of peptides and proteins
11/18/2004	CA2525476A1 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure
11/18/2004	CA2525191A1 Prodrugs cleavable by cd26
11/18/2004	CA2524722A1 Acylated nonadepsipeptides
11/18/2004	CA2524277A1 Arg-pro-pro-gly-phe analogs as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	CA2523765A1 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	CA2523408A1 Peptides for use in treating obesity
11/18/2004	CA2517338A1 Hiv prodrugs cleavable by cd26
11/17/2004	EP1477181A1 Method of stimulating growth and resistance to diseases of aquatic organisms
11/17/2004	EP1476746A2 Method for discovering pharmacologically active substances
11/17/2004	EP1476427A2 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone
11/17/2004	EP1476177A2 Peptide constructs for treating disease

1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 423